- Home
- OCCIM vs QNTM Comparison
OCCIM vs QNTM Comparison
Compare OCCIM & QNTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCCIM
- QNTM
- Stock Information
- Founded
- OCCIM N/A
- QNTM 1998
- Country
- OCCIM
- QNTM Canada
- Employees
- OCCIM N/A
- QNTM N/A
- Industry
- OCCIM
- QNTM
- Sector
- OCCIM
- QNTM
- Exchange
- OCCIM NYSE
- QNTM NYSE
- Market Cap
- OCCIM N/A
- QNTM 9.1M
- IPO Year
- OCCIM N/A
- QNTM N/A
- Fundamental
- Price
- OCCIM $24.81
- QNTM $4.08
- Analyst Decision
- OCCIM
- QNTM
- Analyst Count
- OCCIM 0
- QNTM 0
- Target Price
- OCCIM N/A
- QNTM N/A
- AVG Volume (30 Days)
- OCCIM N/A
- QNTM 220.7K
- Earning Date
- OCCIM N/A
- QNTM 01-14-2025
- Dividend Yield
- OCCIM N/A
- QNTM N/A
- EPS Growth
- OCCIM N/A
- QNTM N/A
- EPS
- OCCIM N/A
- QNTM N/A
- Revenue
- OCCIM N/A
- QNTM N/A
- Revenue This Year
- OCCIM N/A
- QNTM N/A
- Revenue Next Year
- OCCIM N/A
- QNTM N/A
- P/E Ratio
- OCCIM N/A
- QNTM N/A
- Revenue Growth
- OCCIM N/A
- QNTM N/A
- 52 Week Low
- OCCIM N/A
- QNTM $2.70
- 52 Week High
- OCCIM N/A
- QNTM $70.85
- Technical
- Relative Strength Index (RSI)
- OCCIM N/A
- QNTM 49.93
- Support Level
- OCCIM N/A
- QNTM $3.50
- Resistance Level
- OCCIM N/A
- QNTM $4.67
- Average True Range (ATR)
- OCCIM 0.00
- QNTM 0.69
- MACD
- OCCIM 0.00
- QNTM 0.07
- Stochastic Oscillator
- OCCIM 0.00
- QNTM 46.00
About OCCIM OFS CREDIT COMPANY INC 7.875% PREFERRD STCK SERIES F USD25.0
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.
About QNTM QUANTUM BIOPHARMA LTD
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.